Hypertension Drugs Market Players:
- Janssen Global Services, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Atnahs Pharma UK Limited
- Sanofi US Services Inc.
- Pfizer Laboratories Div Pfizer Inc
- Merck & Co., Inc.
- Abbott Laboratories
- Daiichi Sankyo Company, Limited
- Novartis Pharmaceuticals Corporation
- Boehringer Ingelheim group
- Lupin Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of hypertension drugs is estimated at USD 28.73 billion.
The global hypertension drugs market size was around USD 27.8 billion in 2025 and is likely to expand at a CAGR of more than 3.7%, surpassing USD 39.98 billion revenue by 2035.
North America hypertension drugs market is poised to capture 30% share by 2035, driven by the presence of key market players developing innovative hypertension drugs.
Key players in the market include Janssen Global Services, LLC, Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, Novartis Pharmaceuticals Corporation, Boehringer Ingelheim group, Lupin Ltd.
